Portal de Periódicos da CAPES

Isoprostanes

1994; Wiley; Volume: 744; Issue: 1 Linguagem: Inglês

10.1111/j.1749-6632.1994.tb52741.x

1749-6632

L. JACKSON ROBERTS, JASON D. MORROW,

Coenzyme Q10 studies and effects

Annals of the New York Academy of SciencesVolume 744, Issue 1 p. 237-242 Isoprostanes Novel Markers of Endogenous Lipid Peroxidation and Potential Mediators of Oxidant Injurya L. JACKSON ROBERTS II, L. JACKSON ROBERTS II Departments of Pharmacology and Medicine, Vanderbilt University Nashville, Tennessee 37232Search for more papers by this authorJASON D. MORROW, JASON D. MORROW Departments of Pharmacology and Medicine, Vanderbilt University Nashville, Tennessee 37232Search for more papers by this author L. JACKSON ROBERTS II, L. JACKSON ROBERTS II Departments of Pharmacology and Medicine, Vanderbilt University Nashville, Tennessee 37232Search for more papers by this authorJASON D. MORROW, JASON D. MORROW Departments of Pharmacology and Medicine, Vanderbilt University Nashville, Tennessee 37232Search for more papers by this author First published: November 1994 https://doi.org/10.1111/j.1749-6632.1994.tb52741.xCitations: 71 a This work was supported by Grant GM42056 from the National Institutes of Health. J.D.M. is a Howard Hughes Medical Institute Physician Research Fellow and the recipient of a Career Development Award from the International Life Sciences Institute. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Morrow, J. D., K. E. Hill, R. F. Burk, T. M. Nammour, K. F. Badr & L. J. Roberts II. 1990. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical catalyzed mechanism. Proc. Natl. Acad. Sci. USA 87: 9383–9387. 2 Morrow, J. D., J. A. Awad, H. J. Boss, I. A. Blair & L. J. Roberts II. 1992. Noncyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. Proc. Natl. Acad. Sci. USA 89 10721–10725. 3 Banerjee, M., K. H. Kang, J. D. Morrow, L. J. Roberts II & J. H. Newman. 1992. Effects of a novel non-cyclooxygenase derived prostaglandin, 8-epi-PGF2α, in rabbit lung in situ. Am. J. Physiol. 263: (Heart Circ. Physiol. 32): H660–H663. 4 Kang, H. K., J. D. Morrow, L. J. Roberts II, J. H. Newman & M. Banerjee. 1993. Airway and vascular effects of 8-epi-prostaglandin F2α in isolated perfused rat lung. J. Appl. Physiol. 74: 460–465. 5 Takahashi, K., T. M. Nammour, J. Ebert, J. D. Morrow, L. J. Roberts II & K. F. Badr. 1992. Glomerular actions of a free radical generated novel prostaglandin, 8-epi-prostaglandin F2α, in the rat: Evidence for interaction with thromboxane A2 receptors. J. Clin. Invest. 90: 135–141. 6 Morrow, J. D., T. A. Minton & L. J. Roberts II. 1992. The F2-isoprostane, 8-epi-prostaglandin F2α, a potent agonist of the vascular thromboxane/endoperoxide receptor, is a platelet thromboxane/endoperoxide receptor antagonist. Prostaglandins 44: 155–163. 7 Fukunaga, M., N. Makita, L. J. Roberts II, J. D. Morrow, K. Takahashi & K. F. Badr. 1993. Evidence for the existence of F2-isoprostane receptors on rat vascular smooth muscle cells. Am. J. Physiol. 263 (Cell Physiol. 33): C1619–C1624. 8 Morrow, J. D., K. F. Badr & L. J. Roberts II. 1994. Evidence for the formation of the F2-isoprostane, 8-epi-PGF2α, in vivo. Biochim. Biophys. Acta 210: 244–248. 9 Halliwell, B. & M. Grootveld. 1987. The measurement of free radical reactions in humans. FEBS Lett. 21: 9–14. 10 Morrow, J. D., T. M. Harris & L. J. Roberts II. 1990. Non-cyclooxygenase oxidative formation of a series of novel prostaglandins: Analytical ramifications for measurement of eicosanoids. Anal. Biochem. 184: 1–10. 11 Morrow, J. D., J. A. Awad, T. Kato, K. Takahashi, K. F. Badr, L. J. Roberts II & R. F. Burk. 1992. Formation of novel non-cyclooxygenase derived prostanoids (F2-isoprostanes) in carbon tetrachloride hepatotoxicity. An animal model of lipid peroxidation. J. Clin. Invest. 90: 2502–2507. 12 Schelling, J. R. & S. L. Linal. 1990. Hepatorenal syndrome. Semin. Nephrol. 10: 565–570. 13 Harrison, P. M., J. A. Wendon, A. E. S. Gimson, G. J. M. Alexander & R. Williams. 1991. Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N. Engl. J. Med. 324: 1852–1857. 14 Wilkinson, S. P., H. Moodie, J. D. Stamatakis, V. V. Kakkar & R. Williams. 1976. Endotoxaemia and renal failure in cirrhosis and obstructive jaundice. Br. Med. J. 2: 1415–1418. 15 Moore, K., P. S. Ward, G. W. Taylor & R. Williams. 1991. Systemic and renal production of thromboxane A2 and prostacyclin in decompensated liver disease and hepatorenal syndrome. Gastroenterology 100: 1069–1077. 16 Moore, K. P., G. W. Taylor, N. H. Maltby, D. Siegers, R. Fuller, C. T. Dollery & R. Williams. 1990. Increased production of cysteinyl leukotrienes in hepatorenal syndrome. J. Hepatol. 11: 263–271. 17 Moore, K., J. Wendon, M. Frazer, J. Karani, R. Williams & K. Badr. 1992. Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. N. Engl. J. Med. 327: 1774–1778. Citing Literature Volume744, Issue1Cellular Generation, Transport, and Effects of Eicosanoids: Biological Roles and Pharmacological InterventionNovember 1994Pages 237-242 ReferencesRelatedInformation